Evaluation of Home Treatment for Acute Psychiatric Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03320720|
Recruitment Status : Unknown
Verified October 2017 by Matthias Jäger, Psychiatric University Hospital, Zurich.
Recruitment status was: Not yet recruiting
First Posted : October 25, 2017
Last Update Posted : October 25, 2017
|Condition or disease||Intervention/treatment||Phase|
|Mental Disorder||Other: Home Treatment Other: Treatment-as-usual||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||700 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Evaluation of Home Treatment for Acute Psychiatric Care of the Psychiatric University Hospital Zurich (Switzerland)|
|Estimated Study Start Date :||November 2017|
|Estimated Primary Completion Date :||November 2020|
|Estimated Study Completion Date :||November 2020|
Experimental: Home Treatment
Patients with acute mental illness are treated at their houses by a mobile and multiprofessional care team instead of being treated as inpatients if their medical condition permits.
Other: Home Treatment
Patients with acute mental illness in need of inpatient care are treated at their houses by a mobile and multiprofessional care team if their health condition permits.
Active Comparator: Treatment-as-usual
Patients with acute mental illness are treated as inpatients in a psychiatric clinic.
Patients with acute mental illness in need of inpatient care are treated in a psychiatric clinic.
- Inpatient days [ Time Frame: 2 years follow-up ]Number of inpatient days per patient
- Total days in treatment [ Time Frame: 2 years follow-up ]Total days in Treatment per patient = inpatient and home treatment
- Treatment costs [ Time Frame: 2 years follow-up ]Calculated direct treatment costs
- Rehospitalization rate [ Time Frame: 2 years follow-up ]Number of rehospitalizations per patient and duration until rehospitalization
- Adverse events [ Time Frame: 2 years follow-up ]e.g. suicide or attempted suicide
- Global Assessment of Functioning Scale (GAF) [ Time Frame: 2 years follow-up ]Scale measures social, occupational and psychological functioning and ranges from 0 to 100 (higher values mean better outcome).
- Health of the Nation Outcome Scale (HoNOS) [ Time Frame: 2 years follow-up ]Scale measures the severity of symptoms and ranges from 0 to 48 (higher values mean worse outcome).
- Clinical Global Impression Scale (CGI) [ Time Frame: 2 years follow-up ]Scale measures the severity of symptoms, global improvement and therapeutic response and ranges from 0 to 7 (higher values mean worse outcome).
- Patients' satisfaction [ Time Frame: 2 years follow-up ]Patients' satisfaction assessed by the official questionnaire of the national association of the quality development in hospitals (ANQ)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03320720
|Contact: Matthias Jäger, MD||0041 44 384 26 firstname.lastname@example.org|
|Contact: Sonja Mötteli, PhD||0041 44 384 34 email@example.com|
|Principal Investigator:||Matthias Jäger, MD||Psychiatric University Hospital, Zurich|